All articles tagged: Atherosclerotic heart disease of native coronary artery without angina pectoris (I25.10)
![]()
HealthDay
27 June at 09.30 PM
Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019The overall burden of cardiovascular disease (CVD) remained high during 2000 to 2019 in the United Kingdom, according to a study published online June 26 in The BMJ.Nathalie Conrad, Ph.D., from the University of Glasgow in the United Kingdom, and colleagues conducted a population-based study in the United Kingdom to examine the incide |
![]()
HealthDay
27 June at 03.03 PM
hs-cTnT Linked to MACE, Mortality in Rheumatoid ArthritisFor patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of major adverse cardiovascular events (MACE) and all-cause mortality, according to a research letter published online June 15 in the Journal of Rheumatology.Brittany N. Weber, M.D., Ph.D., |
![]()
HealthDay
24 June at 09.20 PM
Childhood Risk Factors Directly Tied to Adult Cardiovascular DiseaseChildhood risk factors are associated both directly and indirectly to adult cardiovascular disease (CVD), according to a study published online June 24 in JAMA Network Open.Noora Kartiosuo, from the University of Turku in Finland, and colleagues quantified the direct and indirect effects of childhood risk factors on adult CVD and t |
![]()
HealthDay
21 June at 03.20 PM
Angiotensin Receptor Blocker Use Linked to Lower Incidence of EpilepsyFor patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other antihypertensive medications, according to a study published online June 17 in JAMA Neurology.Xuerong Wen, Ph.D., from the University of Rhode Island in Kingston, and colleagues conducted a retrosp |
![]()
HealthDay
21 June at 03.06 PM
Fewer Adults Eligible for Statins With PREVENT EquationsUse of the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations reduces the number of adults meeting criteria for primary prevention statin therapy compared with use of the 2013 pooled cohort equations (PCEs), according to a study published online June 10 in JAMA Internal Medicine.Timothy S. Anderson, M.D., from the Univ |
![]()
HealthDay
20 June at 08.50 PM
Timing of Exercise Significant for Obesity, Metabolic ImpairmentFor sedentary adults with obesity/overweight and metabolic impairments, the timing of moderate-to-vigorous physical activity (MVPA) is significant, with a beneficial effect on glucose homeostasis for accumulation of more MVPA in the evening, according to a study published online June 10 in Obesity.Antonio Clavero-Jimeno, from the Univ |
![]()
Evalytics
05 March at 06.03 AM
Metformin's Potential Beyond Diabetes: Exploring Diverse Health BenefitsMetformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp |
![]()
HealthDay
31 January at 04.57 PM
Cardio, Cardio + Resistance Training Improve CVD Risk Profile at One YearIn adults with overweight or obesity, aerobic exercise alone or a combined resistance plus aerobic exercise program leads to improvements in composite cardiovascular disease (CVD) risk profiles at one year, according to a study published online Jan. 17 in the European Heart Journal.Duck-chul Lee, Ph.D., from Iowa State Universit |
![]()
HealthDay
26 January at 10.07 PM
Coronary Artery Disease Testing After Initial Heart Failure Hospitalization Aids OutcomesCoronary artery disease (CAD) testing within 90 days of hospitalization for heart failure is associated with a lower risk for heart failure readmission or all-cause mortality, according to a study published online Jan. 18 in the Journal of General Internal Medicine.Cheng‑Wei Huang, M.D., from Kaiser Permanente Los Angeles Medical C |
![]()
HealthDay
26 January at 03.56 PM
Declines in CVD Mortality Seen From 2010 to 2019 Reversed in 2020Declines in cardiovascular disease (CVD) seen from 2010 to 2019 reversed in 2020 and remained high through 2022, according to a study published online Nov. 14 in the American Journal of Preventive Medicine.Rebecca C. Woodruff, Ph.D., from the U.S. Centers for Disease Control and Prevention in Chamblee, Georgia, and colleagues describe t |
![]()
HealthDay
05 January at 10.37 PM
Statin Initiation Cuts Mortality in Older Adults With Chronic Kidney DiseaseStatin initiation may lower the risk for mortality and major adverse cardiovascular events (MACE) in older adults with chronic kidney disease (CKD) and no prior atherosclerotic cardiovascular disease (ASCVD), according to a study published online Dec. 6 in JAMA Network Open.Odeya Barayev, M.D., from Ben Gurion University of the Nege |
![]()
HealthDay
04 January at 11.57 PM
Risk Prediction Equations for Atherosclerotic CVD Perform Similarly by RaceRisk prediction equations for atherosclerotic cardiovascular disease (ASCVD) perform similarly by race but are worse in men than women, according to a study published online Dec. 6 in JAMA Cardiology.Arnab K. Ghosh, M.D., from Cornell University in New York City, and colleagues quantified the incremental value of race-specific pooled c |
![]()
HealthDay
20 December at 10.06 PM
Blood Pressure, Cholesterol Before Age 55 Years Impact Risk for Heart DiseaseGenetically predicted systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) increase the risk for coronary heart disease (CHD), independent of age, according to a study published online Dec. 20 in PLOS ONE.Nelson Wang, M.D., Ph.D., from the University of New South Wales in Sydney, and colleagues investiga |
![]()
HealthDay
11 December at 11.47 PM
Model Based on Age, Routine Lab Tests Predicts Atherosclerotic CVD AccuratelyThe CANHEART (Cardiovascular Health in Ambulatory Care Research Team) Lab Models can predict atherosclerotic cardiovascular disease (ASCVD) with similar accuracy to more complex models, according to a study published online Dec. 12 in the Annals of Internal Medicine.Maneesh Sud, M.D., Ph.D., from Sunnybrook Health Sciences Centre in Tor |
![]()
HealthDay
05 December at 04.19 PM
Gaps Persist in Actual Versus Optimal Atherosclerotic Cardiovascular Disease CareRoughly half of patients with atherosclerotic cardiovascular disease (ASCVD) adopt optimal prevention strategies across racial and ethnic subgroups, according to a study published online Dec. 1 in JAMA Network Open.Yuan Lu, Sc.D., from Yale New Haven Hospital in Connecticut, and colleagues evaluated trends in racial and ethnic diff |
![]()
HealthDay
04 December at 11.24 PM
Statin Use Increased From 1999-2000 to 2013-2014, Then PlateauedOverall statin use for primary prevention increased since 1999 to 2000 but has plateaued since 2013 to 2014, according to a research letter published online Dec. 5 in the Annals of Internal Medicine.Casey J. Kim, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues describe trends in statin use for primary preven |
![]()
HealthDay
04 December at 05.05 PM
CVD Mortality Similar With Diuretic, ACE Inhibitor, or Calcium Channel BlockerFor patients with hypertension and at least one other coronary heart disease risk factor, cardiovascular disease (CVD) mortality is similar for those receiving a thiazide-type diuretic, calcium channel blocker (CCB), or angiotensin-converting enzyme (ACE) inhibitor, according to a study published online Dec. 4 in JAMA Network Open.Jose-M |
![]()
HealthDay
29 November at 04.49 PM
Coronary Heart Disease, Especially With Early Onset, Linked to DementiaCoronary heart disease (CHD) is associated with increased risks for developing all-cause dementia, Alzheimer disease, and vascular dementia, with higher risks for younger age at CHD onset, according to a study published online Nov. 29 in the Journal of the American Heart Association.Jie Liang, from the Chinese Academy of Medical Scie |
![]()
HealthDay
15 November at 04.56 PM
Changes in Work Environment Can Cut Cardiometabolic RiskIncreasing workplace flexibility is associated with a lower risk for cardiovascular disease, according to a study published online Nov. 8 in the American Journal of Public Health.Lisa F. Berkman, Ph.D., from the Harvard Center for Population and Development Studies in Cambridge, Massachusetts, and colleagues examined whether wor |
![]()
HealthDay
13 November at 04.58 PM
AHA: Daily Marijuana Use Linked to Incident Heart FailureDaily marijuana use is associated with incident heart failure, and cannabis use disorder (CUD) is associated with increased odds of major adverse cardiac and cerebrovascular events (MACCE), according to two studies presented at the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.Yakubu Bene-Alhasan, M |
![]()
HealthDay
30 October at 03.42 PM
No Racial Disparities Seen in Long-Term MACE for Women With CADFor women with obstructive coronary artery disease (CAD), there are no racial and ethnic disparities in long-term major adverse cardiovascular events (MACE) or cardiovascular mortality, according to a research letter published online Oct. 25 in the Canadian Journal of Cardiology.Judy M. Luu, M.D., Ph.D., from McGill University Health Ce |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |